Document is current

Article History

Received: 9 April 2024

Accepted: 29 June 2024

First Online: 27 August 2024

Declarations

:

: N/A.

: N/A.

: RG and NPo report personal fees from Boehringer Ingelheim outside the submitted work. MB and NPa are employees of Boehringer Ingelheim. MRvM reports consulting fees from Boehringer Ingelheim outside the submitted work. Outside the submitted work, MW reports grants or contracts from The Netherlands Organisation for Health Research and Development, The Dutch Lung Foundation, The Dutch Pulmonary Fibrosis Organization, Sarcoidosis.nl, Boehringer Ingelheim, Hoffman La Roche and AstraZeneca-Daiichi, consulting fees from Bristol Myers Squibb, Boehringer Ingelheim, Galapagos, Galecto, Hoffman La Roche, Horizon Therapeutics, Kinevant Sciences, Molecure, Nerre Therapeutics, Novartis, PureTech Health, Thyron, Trevi and Vicore, payments or honoraria from Boehringer Ingelheim, CSL Behring, Hoffman La Roche and Novartis, support for attending meetings/travel from Boehringer Ingelheim, Hoffman La Roche and Galapagos, and participation on a data safety monitoring or advisory board for Savara and Galapagos. All grants and fees were paid to her institution. She also reports that she is Chair of the Idiopathic Interstitial Pneumonia group of the European Respiratory Society, member of the board of the Netherlands Respiratory Society, member of the scientific advisory board of the European Idiopathic Pulmonary Fibrosis and related disorders federation, chair of the educational committee of the European Reference Network for Rare Lung Diseases, and part of an advisory board for the Dutch Lung Fibrosis and Sarcoidosis patient associations.